General Information of Drug Transporter (DT)
DT ID DTD0354 Transporter Info
Gene Name SLC41A1
Transporter Name Magnesium transporter protein solute carrier family 41 member 1
Gene ID
254428
UniProt ID
Q8IVJ1
Post-Translational Modification of This DT
Overview of SLC41A1 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Phosphorylation X-Ubiquitination X: Amino Acid

Phosphorylation

  Serine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC41A1 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

71

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC41A1 Serine 71 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC41A1 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

73

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC41A1 Serine 73 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC41A1 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

76

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC41A1 Serine 76 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC41A1 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

80

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC41A1 Serine 80 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC41A1 [1] , [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

89

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC41A1 Serine 89 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC41A1 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

309

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC41A1 Serine 309 has the potential to affect its expression or activity.

  Threonine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC41A1 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

16

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC41A1 Threonine 16 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC41A1 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

36

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC41A1 Threonine 36 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC41A1 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

81

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC41A1 Threonine 81 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC41A1 [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

312

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC41A1 Threonine 312 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC41A1 [7]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

170

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC41A1 Lysine 170 has the potential to affect its expression or activity.
References
1 Deep Coverage of Global Protein Expression and Phosphorylation in Breast Tumor Cell Lines Using TMT 10-plex Isobaric Labeling. J Proteome Res. 2017 Mar 3;16(3):1121-1132.
2 Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
3 Isoelectric point-based fractionation by HiRIEF coupled to LC-MS allows for in-depth quantitative analysis of the phosphoproteome. Sci Rep. 2017 Jul 3;7(1):4513.
4 Systematic analysis of protein phosphorylation networks from phosphoproteomic data. Mol Cell Proteomics. 2012 Oct;11(10):1070-83.
5 Improved Method for Determining Absolute Phosphorylation Stoichiometry Using Bayesian Statistics and Isobaric Labeling. J Proteome Res. 2017 Nov 3;16(11):4217-4226.
6 Global phosphoproteome analysis of human bone marrow reveals predictive phosphorylation markers for the treatment of acute myeloid leukemia with quizartinib. Leukemia. 2014 Mar;28(3):716-9.
7 A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.